OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
April 06, 2022
ATMPS Ltd has been granted a patent from the United States Patent and Trademark Office for the use of its Hataali blockchain technology used in personalized medicines.
April 05, 2022
Stanley Capital has announced the acquisition of MyMeds&Me by its portfolio company Drug Safety and Pharmacovigilance Services Solutions.
April 01, 2022
Advances in pharmaceutical neuroscience present an opportunity for pharmaceutical companies to stay ahead of the curve.
March 31, 2022
Consumer advocates continue to press for initiatives to lower drug prices by revising or reducing patent protections.
March 15, 2022
CAR-T cell therapy development is a complex process that requires standardization.
The US Congress approved a federal spending package that increases funding for a range of programs to advance health and medicine.
March 11, 2022
Biotech companies and medical product manufacturers have condemned the invasion of Ukraine, while also looking to maintain supplies of essential medicines.
Novartis will pay Voyager up to $1.75 billion for access to Voyager’s novel Tracer AAV capsids for potential use with three CNS targets.
March 09, 2022
A rise in investments and funding into regenerative medicines projects has helped to advance a rich clinical pipeline.
March 03, 2022
A consortium of nine development partners will support Biovac's expansion of its existing vaccine manufacturing plant capacity, while Biovac itself aims to raise funds to boost increased vaccine manufacturing capacity across Africa.